| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.091 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |